Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis
- Conditions
- Polypharmacy (People Under Treatment With 5 or More Drugs)Elderly (People Aged 65 or More)DeprescribingHospitalization
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Regione del Veneto - AULSS n. 7 Pedemontana
- Target Recruit Count
- 100
- Registration Number
- NCT07202962
- Locations
- 🇮🇹
Regione del Veneto - AULSS n. 7 Pedemontana, Santorso, Vicenza, Italy
Study of the Optimal Number of Repetitions to Investigate the Cerebral Activity by fNIRS During a Voluntary Movement and an Illusory Movement Induced by Vibration
- Conditions
- Healthy
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Centre Hospitalier Régional d'Orléans
- Target Recruit Count
- 30
- Registration Number
- NCT07203807
- Locations
- 🇫🇷
CHU Orléans, Orléans, France
Efficacy Study of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in ERCP
- Conditions
- Dexmedetomidine Induced SedationNasal AdministrationSprays
- Interventions
- Drug: Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil InjectionDrug: Normal Saline (nasal spray) + Dexmedetomidine Injection (intravenous) + Propofol Injection + Sufentanil InjectionDrug: Regular sedation protocol
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Shiyou Wei
- Target Recruit Count
- 180
- Registration Number
- NCT07204106
- Locations
- 🇨🇳
Shanghai East Hospital,Affiliated to Tongji University, Shanghai, Shanghai Municipality, China
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- Drug: targeted drug
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 154
- Registration Number
- NCT07203352
- Locations
- 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
- Conditions
- Aging, HealthyBlood Sugar; HighBlood Sugar (Glucose) ControlTime Restricted EatingCircadian Dysregulation
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Salk Institute for Biological Studies
- Target Recruit Count
- 16
- Registration Number
- NCT07203196
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
Ring Free Gingival Techniqea
- Conditions
- Free Gingival Graft Volume Change
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Esra ATEŞ
- Target Recruit Count
- 38
- Registration Number
- NCT07204717
- Locations
Department of Periodontology, Faculty of Dentistry, Bolu Abant İzzet Baysal University,, Bolu, Bolu, Turkey (Türkiye)
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
- Conditions
- Uterine Cervical NeoplasmsHIV I InfectionHPV Infection
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 250
- Registration Number
- NCT07202936
- Locations
- 🇿🇼
Women's Health Centre at Newlands Clinic, Harare, Zimbabwe
A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Beijing Immupeutics Medicine Technology Limited
- Target Recruit Count
- 36
- Registration Number
- NCT07203898
Additional Effects of Niel-asher Technique on Patients With Adhesive Capsulitis
- Conditions
- Adhesive Capsulitis
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Riphah International University
- Target Recruit Count
- 36
- Registration Number
- NCT07203963
- Locations
- 🇵🇰
Shafi International Hospital, Islamabad, Punjab Province, Pakistan
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Xanomeline/ Trospium Chloride
- First Posted Date
- 2025-10-02
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- Karuna Therapeutics
- Target Recruit Count
- 56
- Registration Number
- NCT07204418
- Locations
- 🇺🇸
Local Institution - 0003, Anaheim, California, United States
🇺🇸Local Institution - 0002, Lenexa, Kansas, United States
🇺🇸Local Institution - 0001, San Antonio, Texas, United States